J P de Oliveira, A Levy, P Morel, F Guibal. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AdultAntibodies, Monoclonal/adverse effectsDermatologic Agents/adverse effectsHumansInfliximabLeukocytosis/chemically inducedMaleNeutrophils/pathologyPsoriasis/drug therapy
Substances: See more » Antibodies, MonoclonalDermatologic AgentsInfliximab
Year: 2007 PMID: 18028489 DOI: 10.1111/j.1365-2133.2007.08319.x
Source DB: PubMed Journal: Br J Dermatol ISSN: 0007-0963 Impact factor: 9.302